These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 12769795)
1. Recent knowledge on molecular components of Lewy bodies discloses future therapeutic strategies in Parkinson's disease. Fornai F; Lenzi P; Gesi M; Ferrucci M; Lazzeri G; Natale G; Ruggieri S; Paparelli A Curr Drug Targets CNS Neurol Disord; 2003 Jun; 2(3):149-52. PubMed ID: 12769795 [TBL] [Abstract][Full Text] [Related]
2. The process of Lewy body formation, rather than simply α-synuclein fibrillization, is one of the major drivers of neurodegeneration. Mahul-Mellier AL; Burtscher J; Maharjan N; Weerens L; Croisier M; Kuttler F; Leleu M; Knott GW; Lashuel HA Proc Natl Acad Sci U S A; 2020 Mar; 117(9):4971-4982. PubMed ID: 32075919 [TBL] [Abstract][Full Text] [Related]
10. Propagation of pathological α-synuclein in marmoset brain. Shimozawa A; Ono M; Takahara D; Tarutani A; Imura S; Masuda-Suzukake M; Higuchi M; Yanai K; Hisanaga SI; Hasegawa M Acta Neuropathol Commun; 2017 Feb; 5(1):12. PubMed ID: 28148299 [TBL] [Abstract][Full Text] [Related]
11. Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease. Shimura H; Schlossmacher MG; Hattori N; Frosch MP; Trockenbacher A; Schneider R; Mizuno Y; Kosik KS; Selkoe DJ Science; 2001 Jul; 293(5528):263-9. PubMed ID: 11431533 [TBL] [Abstract][Full Text] [Related]
12. Autophagic adapter protein NBR1 is localized in Lewy bodies and glial cytoplasmic inclusions and is involved in aggregate formation in α-synucleinopathy. Odagiri S; Tanji K; Mori F; Kakita A; Takahashi H; Wakabayashi K Acta Neuropathol; 2012 Aug; 124(2):173-86. PubMed ID: 22484440 [TBL] [Abstract][Full Text] [Related]
13. Accumulation of NEDD8 in neuronal and glial inclusions of neurodegenerative disorders. Mori F; Nishie M; Piao YS; Kito K; Kamitani T; Takahashi H; Wakabayashi K Neuropathol Appl Neurobiol; 2005 Feb; 31(1):53-61. PubMed ID: 15634231 [TBL] [Abstract][Full Text] [Related]
14. UCH-L1 aggresome formation in response to proteasome impairment indicates a role in inclusion formation in Parkinson's disease. Ardley HC; Scott GB; Rose SA; Tan NG; Robinson PA J Neurochem; 2004 Jul; 90(2):379-91. PubMed ID: 15228595 [TBL] [Abstract][Full Text] [Related]
15. Developmental stages of cortical Lewy bodies and their relation to axonal transport blockage in brains of patients with dementia with Lewy bodies. Katsuse O; Iseki E; Marui W; Kosaka K J Neurol Sci; 2003 Jul; 211(1-2):29-35. PubMed ID: 12767494 [TBL] [Abstract][Full Text] [Related]
16. From neurodegeneration to neurohomeostasis: the role of ubiquitin. Mayer RJ Drug News Perspect; 2003 Mar; 16(2):103-8. PubMed ID: 12792671 [TBL] [Abstract][Full Text] [Related]
18. Lewy body extracts from Parkinson disease brains trigger α-synuclein pathology and neurodegeneration in mice and monkeys. Recasens A; Dehay B; Bové J; Carballo-Carbajal I; Dovero S; Pérez-Villalba A; Fernagut PO; Blesa J; Parent A; Perier C; Fariñas I; Obeso JA; Bezard E; Vila M Ann Neurol; 2014 Mar; 75(3):351-62. PubMed ID: 24243558 [TBL] [Abstract][Full Text] [Related]
19. Mechanisms of Parkinson's disease linked to pathological alpha-synuclein: new targets for drug discovery. Lee VM; Trojanowski JQ Neuron; 2006 Oct; 52(1):33-8. PubMed ID: 17015225 [TBL] [Abstract][Full Text] [Related]
20. Morphogenesis of Lewy bodies: dissimilar incorporation of alpha-synuclein, ubiquitin, and p62. Kuusisto E; Parkkinen L; Alafuzoff I J Neuropathol Exp Neurol; 2003 Dec; 62(12):1241-53. PubMed ID: 14692700 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]